The government has sent Johnson & Johnson the formula devised to compensate patients for the faulty hip implants. The firm has sought some time to respond.
Compensation for the faulty J&J hip implants will be the first ever highest paid relief to disabled patients in India, says Drug Controller General of India.
While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS